santosh006

SUBMITTED BY: santosh006

DATE: July 19, 2022, 9:55 a.m.

FORMAT: Text only

SIZE: 4.2 kB

Raw Download

HITS: 392

Report
  1. Antibiotics Market Set for Rapid Growth
  4. According to the latest study on ‘Antibiotics Market Forecast to 2028 - Covid-19 Impact and Global Analysis by Drug Class and Action Mechanism.’ The global antibiotics market was valued at US$ 44,111.31 million in 2020 and is projected to reach US$ 59,253.24 million in 2028; it is expected to grow at a CAGR of 4.0% during 2021–2028. The report provides trends prevailing in the global antibiotics market and the factors driving market along with those that act as hindrances.
  6. Based on n drug class, the antibiotics market is segmented into Cephalosporin, Penicillin, Fluoroquinolones, Macrolides, Carbapenem, Aminoglycosides, Sulfonamides, and Others. The cephalosporin segment held the largest share of the market in 2020; however the fluoroquinolones segment is anticipated to register the highest CAGR of 5.3% in the market during the forecast period. Additionally, increasing incidence of pneumonia, bloodstream infections, and Urinary Tract Infections (UTI) is expected to increase the demand for carbapenems class of antibiotics in coming years. Moreover, the lower price of generic carbapenem-based antibiotics is expected to result in increased product adoption, thus compelling carbapenem-based antibiotic manufacturers to develop geographical footprint in lower and middle-income countries.
  8. The growth of the market is attributed to some of the key factors, such as rising prevalence of bacterial infections and increasing development of generic drugs. However, challenges associated with tedious and expensive process of antibiotic development and due to coronavirus pandemic are expected to restraint the growth of the market during the forecast years.
  10. Pfizer, Inc., Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals), Abbott, GlaxoSmithKine Plc, Sanofi, Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, and Astellas Pharma are among the leading companies operating in the antibiotics market. The companies are focused towards the adoption of organic strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in May 2017, Pfizer's launched new antibiotic for multidrug resistant (MDR) infections Zavicefta in the UK and Germany, its first lauch was in EU markets.
  12. Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00003406/
  14. The report segments global antibiotics market as follows:
  16. By Drug Class
  18. Cephalosporin
  19. Penicillin
  20. Fluoroquinolones
  21. Macrolides
  22. Carbapenem
  23. Aminoglycosides
  24. Sulfonamides
  25. Others
  26. By Action Mechanism
  28. Cell Wall Synthesis Inhibitors
  29. Protein Synthesis Inhibitors
  30. DNA Synthesis Inhibitors
  31. RNA Synthesis Inhibitors
  32. Mycolic Acid Inhibitors
  33. Others
  34. By Geography
  36. North America
  37. US
  38. Canada
  39. Mexico
  40. Europe
  41. France
  42. Germany
  43. UK
  44. Spain
  45. Italy
  46. Asia Pacific (APAC)
  47. China
  48. India
  49. Japan
  50. Australia
  51. South Korea
  52. Middle East and Africa (MEA)
  53. Saudi Arabia
  54. UAE
  55. South Africa
  56. South & Central America (SCAM)
  57. Brazil
  58. Argentina
  59. Buy Now: https://www.theinsightpartners.com/buy/TIPRE00003406/
  61. Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin, Others); Action Mechanism (Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors), and Geography
  63. About Us:
  65. The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
  67. Contact Us:
  69. If you have any queries about this report or if you would like further information, please contact us:
  71. Contact Person: Sameer Joshi
  73. E-mail: sales@theinsightpartners.com
  75. Phone: +1-646-491-9876
comments powered by Disqus